Trial | NCT02244515  Report issue

Official Title

Consequence of Dexmedetomidine on Emergence Deliruim After Sevoflurane Anesthesia in Children With Cerebral Palsy

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Unknown status

  • Study Participants

    80
The purpose of this study is to determine whether dexmedetomidine is effective in the treatment of emergence deliruim after sevoflurane anesthesia in children with cerebral palsy.
Study Started
Jun 30
2014
Primary Completion
Sep 30
2014
Last Update
Sep 19
2014
Estimate

Drug dexmedetomidine

dexmedetomidine 0.5μg•kg-1 diluted in 10 ml NaCI 0.9%

Group C Placebo Comparator

Five minutes prior to the commencement of the surgical procedure, Group D participants were administered 10 ml NaCI 0.9%.

Group D Experimental

Five minutes prior to the commencement of the surgical procedure, Group D participants were administered dexmedetomidine 0.5μg•kg-1 diluted in 10 ml NaCI 0.9%

Criteria 

Inclusion Criteria:

Non-quadriplegic (mono-,di-, hemiplegic) children with CP that are scheduled for elective Achilles-tendon lengthening procedure Guangzhou Women and Children's Medical Center, Guangzhou, China, with American Society of Anesthesiologists (ASA) physical status I or II.

Exclusion Criteria:

Participants that displayed symptoms of sinus bradycardia and atrio-ventricular block, non-communicative severe developmental delay, seizure disorders, and treatment with seizure medications
No Results Posted